[1]
Trajkova, S., Stavridis, I.P., Stojanovic, A., Petrusevska, G., Dukovski, D., Ivanovski, M., Veljanovska, A.P., Simjanovska, M.P., Cadievski, L. and Cevreska, L. 2017. Immunoblastic morphology as a possible prognostic indicator for the outcome of the patients with diffuse large B cell lymphoma in era of the rituximab based treatment: single centre experience. International Journal of Research in Medical Sciences. 1, 2 (Jan. 2017), 47–52.